QualityStocksNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Integrates Radiation Dose Personalization into IzoView Breast CT System
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company focused on advanced breast cancer imaging technologies, announced the integration of a patent-pending radiation dose personalization feature into its IzoView Breast CT Imaging System. The innovation uses a radiation-free optical pre-scan and proprietary software to calculate customized dosing for each patient’s breast size, streamlining exam setup and improving comfort. Developed using models from UC Davis Medical Center, the system positions IzoView as the first breast CT to offer real-time personalized dosing. With the global breast imaging market projected to grow to $8.69 billion by 2030, Izotropic is advancing IzoView…